drugset / Trial / NCT06235203
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Phase 3
Recruiting
154 enrolled
Eye & ENT Hospital of Fudan University
Changhai Hospital · collabFujian Medical University Union Hospital · collabPeople's Hospital of Guangxi Zhuang Autonomous Region · collabShanghai 6th People's Hospital · collabShanghai Zhongshan Hospital · collabShenzhen Second People's Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
A multicenter randomized controlled study of surgery combined with neoadjuvant and adjuvant therapy for locally advanced recurrent nasopharyngeal carcinoma in comparison to surgery combined with adjuvant therapy
Timeline
- Start
- 2024-07-09
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Toripalimab | Monoclonal antibody | — | — |